Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
State Street Utilities Select Sector SPDR ETF
XLU
$23B
| $336M | 0.15% |
9,535,734
-3,199,942
| -25% | -$109M |
|
102
CVS Health
CVS
$134B
| $336M | 0.15% |
3,603,998
+763,870
| +27% | +$73.7M |
|
103
IBM
IBM
$209B
| $334M | 0.15% |
2,371,263
+741,604
| +46% | +$102M |
|
104
Bristol-Myers Squibb
BMY
$132B
| $331M | 0.15% |
4,603,926
+658,936
| +17% | +$49.7M |
|
105
Colgate-Palmolive
CL
$73.3B
| $327M | 0.15% |
4,145,088
+2,079,979
| +101% | +$156M |
|
106
RTX Corp
RTX
$289B
| $321M | 0.14% |
3,178,556
+1,492,843
| +89% | +$140M |
|
107
S&P Global
SPGI
$122B
| $319M | 0.14% |
951,753
+268,888
| +39% | +$88.6M |
|
|
108
PUT
NVIDIA
NVDA
$4.72T
| $311M | 0.14% |
+21,289,000
| New | +$312M |
|
109
PayPal
PYPL
$49.3B
| $308M | 0.14% |
4,321,946
+1,057,221
| +32% | +$84.6M |
|
110
MetLife
MET
$62.5B
| $305M | 0.14% |
4,212,766
-1,051,904
| -20% | -$75.3M |
|
111
Monster Beverage
MNST
$95.5B
| $305M | 0.14% |
6,001,420
+2,037,072
| +51% | +$98.7M |
|
|
112
CALL
Apple
AAPL
$4.9T
| $304M | 0.14% |
+2,338,200
| New | +$334M |
|
113
AT&T
T
$159B
| $302M | 0.14% |
16,395,685
+5,210,542
| +47% | +$93.3M |
|
|
ATVI
114
DELISTED
Activision Blizzard
ATVI
| $301M | 0.13% |
3,928,009
+501,836
| +15% | +$37.3M |
|
115
PUT
Visa
V
$673B
| $300M | 0.13% |
+1,441,600
| New | +$291M |
|
116
Boeing
BA
$175B
| $298M | 0.13% |
1,564,623
-330,130
| -17% | -$54M |
|
117
Pinduoduo
PDD
$124B
| $297M | 0.13% |
3,636,383
+452,682
| +14% | +$31.5M |
|
118
Applied Materials
AMAT
$398B
| $295M | 0.13% |
3,028,819
+604,586
| +25% | +$58M |
|
119
TJX Companies
TJX
$176B
| $291M | 0.13% |
3,658,814
+1,504,026
| +70% | +$111M |
|
120
Mettler-Toledo International
MTD
$27.9B
| $289M | 0.13% |
200,172
+3,057
| +2% | +$4.09M |
|
121
Kinross Gold
KGC
$28.2B
| $288M | 0.13% |
70,356,399
-5,049,458
| -7% | -$20M |
|
122
United Parcel Service
UPS
$89.5B
| $286M | 0.13% |
1,647,276
+660,234
| +67% | +$114M |
|
123
3M
MMM
$90.8B
| $286M | 0.13% |
2,847,781
+1,877,702
| +194% | +$191M |
|
124
Roper Technologies
ROP
$38.5B
| $283M | 0.13% |
654,794
+10,691
| +2% | +$4.4M |
|
|
125
PUT
Boeing
BA
$175B
| $283M | 0.13% |
+1,485,000
| New | +$243M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.